Expanded Molecular Testing on Patients with Suspected West Nile Virus Disease
Supporting Files
-
May 13 2019
-
File Language:
English
Details
-
Alternative Title:Vector Borne Zoonotic Dis
-
Personal Author:Lindsey, Nicole P. ; Messenger, Sharon L. ; Hacker, Jill K. ; Salas, Maria L. ; Scott-Waldron, Christine ; Haydel, Danielle ; Rider, Errin ; Simonson, Sean ; Brown, Catherine M. ; Patel, Pinal ; Smole, Sandra C. ; Neitzel, David F. ; Schiffman, Elizabeth K. ; Palm, Jennifer ; Strain, Anna K. ; Vetter, Sara M. ; Nefzger, Brian ; Fischer, Marc ; Rabe, lngrid B.
-
Description:Most diagnostic testing for West Nile virus (WNV) disease is accomplished using serologic testing, which is subject to cross-reactivity, may require cumbersome confirmatory testing, and may fail to detect infection in specimens collected early in the course of illness. The objective of this project was to determine whether a combination of molecular and serologic testing would increase detection of WNV disease cases in acute serum samples. A total of 380 serum specimens collected ≤7 days after onset of symptoms and submitted to four state public health laboratories for WNV diagnostic testing in 2014 and 2015 were tested. WNV immunoglobulin M (IgM) antibody and RT-PCR tests were performed on specimens collected ≤3 days after symptom onset. WNV IgM antibody testing was performed on specimens collected 4-7 days after onset and RT-PCR was performed on IgM-positive specimens. A patient was considered to have laboratory evidence of WNV infection if they had detectable WNV IgM antibodies or WNV RNA in the submitted serum specimen. Of specimens collected ≤3 days after symptom onset, 19/158 (12%) had laboratory evidence of WNV infection, including 16 positive for only WNV IgM antibodies, 1 positive for only WNV RNA, and 2 positive for both. Of specimens collected 4-7 days after onset, 21/222 (9%) were positive for WNV IgM antibodies; none had detectable WNV RNA. These findings suggest that routinely performing WNV RT-PCR on acute serum specimens submitted for WNV diagnostic testing is unlikely to identify a substantial number of additional cases beyond IgM antibody testing alone.
-
Subjects:
-
Source:Vector Borne Zoonotic Dis. 19(9):690-693
-
Pubmed ID:31081745
-
Pubmed Central ID:PMC7135921
-
Document Type:
-
Funding:
-
Volume:19
-
Issue:9
-
Collection(s):
-
Main Document Checksum:urn:sha256:4a9093ffade0447783e668e5df9a44eeb5d461c9a972878d4c2c4148fea7be05
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access